Medtronic announced a strategic partnership with Methinks AI, a leading provider of AI-driven radiological triage and notification systems, to enhance stroke treatment across Central and Eastern Europe, Africa, Türkiye, and the Middle East. This collaboration supports Medtronic’s Neurovascular business by integrating advanced AI solutions into its stroke care portfolio. Financial terms of the partnership were not disclosed.
Methinks AI’s Impact
Methinks AI’s solutions, validated in renowned hospitals across Europe and the U.S., excel in detecting over 80% of large vessel occlusions using non-contrast CT imaging. This capability ensures faster assessment, even in settings with limited access to advanced imaging technologies, reducing critical delays in treatment. The partnership with Microsoft further enhances the scalability and accessibility of this life-saving technology.
Collaboration Benefits
This collaboration underscores the importance of integrating innovative services and solutions to optimize procedural support and patient pathways in stroke care. By combining Methinks AI’s technology with Medtronic’s stroke treatment portfolio, the partnership will streamline connectivity between stroke centers and regional hospitals, enabling seamless patient triage and care coordination. The software’s ability to assess strokes directly from non-contrast CT scans empowers healthcare providers with timely decision-making tools, ultimately improving patient outcomes.-Fineline Info & Tech